Search Within

Emily Kanaya Slotkin

Formats
  1. Journal Article (34)
  2. Meeting Abstract (26)
  3. Editorial (2)
  4. Review (2)
  5. Guidelines (1)
Groups
  1. Pediatrics, Department of (65)
  2. Sarcoma Service (Pediatrics) (65)
  3. GSK Faculty (32)
  4. Department of Pathology and Laboratory Medicine (31)
  5. Tow Center for Developmental Oncology (TCDO) (31)
  6. Center for Hematologic Malignancies (30)

More Groups

People
  1. Leonard Wexler (20)
  2. William Tap (18)
  3. Paul Meyers (17)
  4. Michael Ortiz (16)
  5. Neerav Shukla (16)
  6. Marc Ladanyi (15)

More People

Years
  1. 2025 (3)
  2. 2024 (5)
  3. 2023 (7)
  4. 2022 (13)
  5. 2021 (7)
  6. 2020 (9)

More Years

Publications
  1. Pediatric Blood and Cancer (13)
  2. Journal of Clinical Oncology (12)
  3. Clinical Cancer Research (7)
  4. Cancer Research (6)
  5. JCO Precision Oncology (3)
  6. Nature Communications (3)

More Publications

Publishers
  1. American Association for Cancer Research (16)
  2. American Society of Clinical Oncology (15)
  3. Wiley Periodicals, Inc (13)
  4. Nature Publishing Group (4)
  5. Elsevier Inc. (3)
  6. Wiley Blackwell (3)

More Publishers

Results (65)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Standardizing premedication for blood product transfusions: A prospective qi initiative
    Meeting Abstract

    Shahid, S.; Lucas, A. T.; Rosenzweig, J.; McThenia, S.; Degliuomini, M.; Fong, C.; Wuest, D.; Kaicker, S.; Slotkin, E.
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Phase 1 trial of GD2-SADA: (177)Lu-DOTA drug complex in patients with recurrent or refractory metastatic solid tumors known to express GD2 including small cell lung cancer (SCLC), sarcoma, and malignant melanoma
    Meeting Abstract

    Owonikoko, T. K.; Moser, J. C.; Yoon, J.; Slotkin, E. K.; Dowlati, A.; Ma, V. T.; Dùˆring, M.; Sveistrup, J.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
    Review

    Pearson, A. D. J.; Federico, S.; Gatz, S. A.; Ortiz, M.; Lesa, G.; Scobie, N.; Gounaris, I.; Weiner, S. L.; Weigel, B.; Unger, T. J.; more...
    European Journal of Cancer (2023)

    Fulltext@MSK | Save
  • Pediatric DDR inhibitor combinations: Are WEE1 there yet?
    Editorial

    Slotkin, E. K.; Ortiz, M. V.; Glade Bender, J. L.
    Cancer (2023)

    Fulltext@MSK | Save
  • Irinotecan dose schedule for the treatment of Ewing sarcoma
    Review

    Slotkin, E. K.; Meyers, P. A.
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Prospective clinical genomic profiling of Ewing sarcoma: ERF and FGFR1 mutations as recurrent secondary alterations of potential biologic and therapeutic relevance
    Journal Article

    Ogura, K.; Elkrief, A.; Bowman, A. S.; Koche, R. P.; de Stanchina, E.; Benayed, R.; Mauguen, A.; Mattar, M. S.; Khodos, I.; Meyers, P. A.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Development of a patient-derived xenograft (PDX) modeling program to enable pediatric precision medicine
    Meeting Abstract

    Dela Cruz, F. S.; McCarter, J. G.; You, D.; Bouvier, N.; Wang, X.; Guillan, K. C.; Siddiquee, A. H.; Souto, K. B.; Li, H.; Gao, T.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Targeted sequencing of 2,138 bone and soft tissue sarcomas reveals commonly altered pathways, subtype-independent genetic clusters, and potential therapeutic targets
    Meeting Abstract

    Nacev, B. A.; Sanchez-Vega, F.; Smith, S.; Antonescu, C.; Rosenbaum, E.; Shi, H.; Tang, C.; Socci, N.; Rana, S.; Gularte-Merida, R.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • To premedicate or not? A look at premedications for blood product transfusions at MSK kids
    Meeting Abstract

    Rosenzweig, J.; Troullioud Lucas, A.; Shahid, S.; Mcthenia, S.; Fong, C.; Degliuomini, M.; Kaicker, S.; Slotkin, E.
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • A phase I/II study of prexasertib in combination with irinotecan in patients with relapsed/refractory desmoplastic small round cell tumor and rhabdomyosarcoma
    Meeting Abstract

    Slotkin, E. K.; Mauguen, A.; Ortiz, M. V.; Dela Cruz, F. S.; O'Donohue, T.; Kinnaman, M. D.; Meyers, P. A.; Wexler, L. H.; Rodriguez, S.; Avutu, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save